0101.KLSE TMC Life Sciences Bhd

Healthcare Health Care Providers & Services Kuala Lumpur Exchange
0.4150 MYR
Close of Oct 29, 2026
0.4050 0.5650
Market cap
MYR 723M
P/E
41.5x
P/B
0.82x
ROE
2.0%
Dividend yield
0.45%
Fundamental score
2.5/5

Ratios use the latest price and the fiscal year ending Aug 2026.

Is 0101.KLSE undervalued?

Graham number
Price0.4150
Graham value0.3367
Premium23.3%

0101.KLSE trades 23.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TMC Life Sciences Bhd fundamental analysis

12 of 22 checks passed

ROE 0/2

Low return on equity (2.0%), below 10%.

ROA 0/1

Return on assets (1.6%) is below the industry median (3.7%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (382.0%) is above the 5-year average (-3.0% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (382.0%) is above the industry median (6.1%).

Revenue Growth 1/2

Revenue grew 8.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (16.7%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

EBIT is 3.7x against interest expense, below 5x.

PE vs Market 0/1

PE (41.5x) is above the market median (11.4x).

PE vs Industry 0/1

PE (41.5x) is above the industry median (27.9x).

PBV 1/1

Price to book (0.8x) is below the industry median (2.2x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 34.2, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (0.4%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 18.7%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About TMC Life Sciences Bhd

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support servi…

Full company profile